Merck & Company, Inc. News Headlines

Get MRK Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Eli Lilly/Boehringer's Diabetes Drug Under FDA Review - Analyst Blog
10/23/2014 3:30:00 PM -

Gilead's Hep C Dream Drug Faces Demanding Investors
10/22/2014 3:44:00 PM - Investor's Business Daily

5-Star And Dow Analysts Give 9% Edge To Lowest-Priced High-Yield Stocks
10/22/2014 9:42:00 AM - Seeking Alpha

Gilead Sciences: Pricing, Politics And Profits
10/21/2014 3:23:00 PM - Seeking Alpha

Market Reaction To Johnson & Johnson's Earnings Is Justified
10/21/2014 12:54:38 PM - Trefis

Gilead Sciences: Clear The Dockets And Settle With Merck Already
10/21/2014 9:07:00 AM - Seeking Alpha

Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2014 Update
10/21/2014 4:52:00 AM - Seeking Alpha

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog
10/20/2014 5:15:00 PM -

Interesting April 2015 Stock Options for MRK
10/20/2014 11:17:28 AM - BNK Invest

Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha

This Drug Could Outsell Medical Marijuana
10/19/2014 11:02:02 AM - Motley Fool

Confused, Bothered And Bewildered
10/18/2014 6:18:00 PM - Seeking Alpha

Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
10/18/2014 1:07:02 PM - Motley Fool

A Harvoni Vs. Olysio Price War Will Be Nonexistent: Consider Buying Gilead Now
10/17/2014 1:54:00 PM - Seeking Alpha

DLN, T, PFE, MRK: Large Inflows Detected at ETF
10/17/2014 9:56:02 AM - BNK Invest

With Strong Corporate Partnerships, Xenon Pharmaceuticals IPO Looks Appealing
10/16/2014 9:49:00 PM - Seeking Alpha

IPO Preview: Xenon Pharmaceuticals
10/16/2014 11:43:00 AM - Seeking Alpha

Dow Movers: MRK, UNH
10/16/2014 10:59:35 AM - BNK Invest

Dogs Of The Dow: 2014 Third Quarter Review
10/15/2014 4:14:00 PM - Seeking Alpha

Gilead's Harvoni Will Dominate J&J's Olysio In HCV: Is Olysio Even Relevant Anymore?
10/15/2014 9:24:00 AM - Seeking Alpha

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
10/15/2014 7:45:02 AM - Motley Fool

Merck Still Looks Very Expensive
10/14/2014 3:02:00 PM - Seeking Alpha

Can Dividend Stock GlaxoSmithKline plc Bounce Back?
10/14/2014 12:09:05 PM - Motley Fool

How Retirees Made It Through The Last 2 Recessions
10/14/2014 11:41:00 AM - Seeking Alpha

Merck: Be Prepared For A Buying Opportunity From A Dividend Perspective
10/14/2014 8:03:00 AM - Seeking Alpha